Trial Profile
Retrospective study of pamidronate use in the pediatric patients with osteogenesis imperfecta at Boston Children's Hospital
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Apr 2014
Price :
$35
*
At a glance
- Drugs Pamidronic acid (Primary)
- Indications Osteogenesis imperfecta
- Focus Adverse reactions; Therapeutic Use
- 18 Apr 2014 New trial record